NRXPのPER（株価収益率）は？

NRX PHARMACEUTICALS INC（NRXP）は現在PER 370.94倍で取引されています。

NRXPのROE（自己資本利益率）は？

NRX PHARMACEUTICALS INCのROEは177.63%です。

NRXPの配当利回りは？

NRX PHARMACEUTICALS INCの配当利回りは0.00%です。

NRXPの品質スコア（Quality Score）は？

当社のAIはNRXPの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

NRXPは今が買い時ですか？

当社AIのタイミングスコアは100点中56点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

NRXPはどのセクターに属しますか？

NRX PHARMACEUTICALS INCはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

NRXP (NASDAQ) 株価分析 | NRX PHARMACEUTICALS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

NRXP AI Analysis Summary

Our AI summary for NRXP: NRX PHARMACEUTICALS INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 370.94, ROE of 177.63%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 56/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

NRXP

NRX PHARMACEUTICALS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 59

USD 3.15

0.03 (0.96%) Day Change

Watchlist Portfolio Compare Chart

370.94

P/E

-0.03

D/E

177.6%

ROE

-206.2%

ROA

0.00%

Div Yield

2.35

PEG

NRX PHARMACEUTICALS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.15 Price 0.03 (0.96%) Day Change	NEWS SCORE: 59

NRXP, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROAが低い
ROEの伸びが低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	59
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.15
PBV / Sector	-9.67 / 5.20
Earning Per Share	-0.58

PE / Sector	370.94 / 19.97
PEG or PE/Growth / Sector	2.35 / 1.22
Average 1M Daily Value	3.42 M GREAT
Average 1W Daily Value	3.88 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1,070.26 / 98.71
NPM Average (%) / Sector	-1,703.37 / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-206.17 / 27.02
ROA Average (%) / Sector	-336.29 / -368.17
ROA Change Average (%) / Sector	40.01 / 5,404.12 GREAT
ROE (%) / Sector	177.63 / 3.47 GREAT
ROE Average (%) / Sector	37.16 / 6.51 GREAT
ROE Change Average (%) / Sector	-35.22 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 08:00:14
Symbol	NRXP
Name	NRX PHARMACEUTICALS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	42.80 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	133.54 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1201 N. Market Street, Wilmington, DE, United States, 19801

Phone: 484 254 6134

Website: https://www.nrxpharma.com

Sector: Healthcare >> Biotechnology

Description: NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.